MERCK Kommanditgesellschaft auf Aktien (MRK.DE)
EUR 134.2
(-0.26%)
EUR 134.2
(-0.26%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 22.36 Billion EUR | -0.68% |
| 2022 | 22.52 Billion EUR | -5.95% |
| 2021 | 23.94 Billion EUR | -3.36% |
| 2020 | 24.77 Billion EUR | -4.32% |
| 2019 | 25.89 Billion EUR | 31.76% |
| 2018 | 19.65 Billion EUR | -8.81% |
| 2017 | 21.55 Billion EUR | -10.93% |
| 2016 | 24.2 Billion EUR | -3.78% |
| 2015 | 25.15 Billion EUR | 77.01% |
| 2014 | 14.2 Billion EUR | 45.74% |
| 2013 | 9.74 Billion EUR | -13.17% |
| 2012 | 11.22 Billion EUR | -3.42% |
| 2011 | 11.62 Billion EUR | -3.24% |
| 2010 | 12.01 Billion EUR | 66.91% |
| 2009 | 7.19 Billion EUR | 19.5% |
| 2008 | 6.02 Billion EUR | -3.38% |
| 2007 | 6.23 Billion EUR | 45.16% |
| 2006 | 4.29 Billion EUR | 8.69% |
| 2005 | 3.95 Billion EUR | 39.77% |
| 2004 | 2.82 Billion EUR | -38.79% |
| 2003 | 4.61 Billion EUR | -15.36% |
| 2002 | 5.45 Billion EUR | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q2 | 21.25 Billion EUR | -0.81% |
| 2024 Q1 | 21.43 Billion EUR | -4.18% |
| 2023 FY | 22.36 Billion EUR | -0.68% |
| 2023 Q4 | 22.36 Billion EUR | 3.5% |
| 2023 Q3 | 21.61 Billion EUR | -1.81% |
| 2023 Q1 | 22.4 Billion EUR | -0.51% |
| 2023 Q2 | 22.01 Billion EUR | -1.77% |
| 2022 Q3 | 22.59 Billion EUR | -0.41% |
| 2022 FY | 22.52 Billion EUR | -5.95% |
| 2022 Q2 | 22.68 Billion EUR | -2.4% |
| 2022 Q1 | 23.24 Billion EUR | -2.93% |
| 2022 Q4 | 22.52 Billion EUR | -0.33% |
| 2021 Q2 | 23.78 Billion EUR | -4.51% |
| 2021 Q4 | 23.94 Billion EUR | 3.41% |
| 2021 Q3 | 23.15 Billion EUR | -2.64% |
| 2021 FY | 23.94 Billion EUR | -3.36% |
| 2021 Q1 | 24.9 Billion EUR | 0.52% |
| 2020 Q2 | 25.79 Billion EUR | -1.33% |
| 2020 Q1 | 26.14 Billion EUR | 0.95% |
| 2020 Q3 | 25.23 Billion EUR | -2.17% |
| 2020 Q4 | 24.77 Billion EUR | -1.81% |
| 2020 FY | 24.77 Billion EUR | -4.32% |
| 2019 Q4 | 25.89 Billion EUR | 8.43% |
| 2019 Q1 | 21.04 Billion EUR | 7.06% |
| 2019 Q2 | 21.99 Billion EUR | 4.52% |
| 2019 Q3 | 23.88 Billion EUR | 8.6% |
| 2019 FY | 25.89 Billion EUR | 31.76% |
| 2018 FY | 19.65 Billion EUR | -8.81% |
| 2018 Q1 | 21.07 Billion EUR | -2.25% |
| 2018 Q2 | 20.93 Billion EUR | -0.65% |
| 2018 Q3 | 20.39 Billion EUR | -2.58% |
| 2018 Q4 | 19.65 Billion EUR | -3.62% |
| 2017 Q1 | 23.87 Billion EUR | -1.37% |
| 2017 Q4 | 21.55 Billion EUR | -2.2% |
| 2017 Q3 | 22.03 Billion EUR | -4.22% |
| 2017 Q2 | 23 Billion EUR | -3.61% |
| 2017 FY | 21.55 Billion EUR | -10.93% |
| 2016 Q4 | 24.2 Billion EUR | 1.9% |
| 2016 Q3 | 23.75 Billion EUR | -1.74% |
| 2016 Q2 | 24.17 Billion EUR | -1.78% |
| 2016 FY | 24.2 Billion EUR | -3.78% |
| 2016 Q1 | 24.6 Billion EUR | -2.16% |
| 2015 Q2 | 15.9 Billion EUR | -6.13% |
| 2015 Q3 | 18.24 Billion EUR | 14.73% |
| 2015 Q1 | 16.93 Billion EUR | 19.2% |
| 2015 FY | 25.15 Billion EUR | 77.01% |
| 2015 Q4 | 25.15 Billion EUR | 37.88% |
| 2014 FY | 14.2 Billion EUR | 45.74% |
| 2014 Q2 | 10.26 Billion EUR | 5.07% |
| 2014 Q1 | 9.76 Billion EUR | 0.17% |
| 2014 Q4 | 14.2 Billion EUR | 29.93% |
| 2014 Q3 | 10.93 Billion EUR | 6.58% |
| 2013 Q1 | 11.43 Billion EUR | 1.88% |
| 2013 FY | 9.74 Billion EUR | -13.17% |
| 2013 Q4 | 9.74 Billion EUR | -7.55% |
| 2013 Q3 | 10.54 Billion EUR | -6.31% |
| 2013 Q2 | 11.25 Billion EUR | -1.61% |
| 2012 Q3 | 11.7 Billion EUR | 3.03% |
| 2012 Q4 | 11.22 Billion EUR | -4.09% |
| 2012 FY | 11.22 Billion EUR | -3.42% |
| 2012 Q1 | 10.85 Billion EUR | -6.66% |
| 2012 Q2 | 11.36 Billion EUR | 4.7% |
| 2011 Q3 | 11.95 Billion EUR | 3.64% |
| 2011 FY | 11.62 Billion EUR | -3.24% |
| 2011 Q1 | 11.63 Billion EUR | -3.14% |
| 2011 Q2 | 11.53 Billion EUR | -0.87% |
| 2011 Q4 | 11.62 Billion EUR | -2.77% |
| 2010 Q2 | 11.49 Billion EUR | 8.64% |
| 2010 Q1 | 10.57 Billion EUR | 46.91% |
| 2010 FY | 12.01 Billion EUR | 66.91% |
| 2010 Q4 | 12.01 Billion EUR | -3.7% |
| 2010 Q3 | 12.47 Billion EUR | 8.6% |
| 2009 FY | 7.19 Billion EUR | 19.5% |
| 2009 Q4 | 7.19 Billion EUR | 0.0% |
| 2008 FY | 6.02 Billion EUR | -3.38% |
| 2007 FY | 6.23 Billion EUR | 45.16% |
| 2006 FY | 4.29 Billion EUR | 8.69% |
| 2005 FY | 3.95 Billion EUR | 39.77% |
| 2004 FY | 2.82 Billion EUR | -38.79% |
| 2003 FY | 4.61 Billion EUR | -15.36% |
| 2002 FY | 5.45 Billion EUR | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| MPH Health Care AG | 15.38 Million EUR | -145267.825% |
| Apontis Pharma AG | 27.2 Million EUR | -82131.618% |
| Dermapharm Holding SE | 1.62 Billion EUR | -1274.931% |
| Evotec SE | 1.17 Billion EUR | -1796.883% |
| PharmaSGP Holding SE | 91.54 Million EUR | -24332.793% |
| SynBiotic SE | 19.59 Million EUR | -114069.964% |